Digoxin

This classification denotes a saponin and cardiotonic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 73K4184T59. European Medicines Agency schedules Digoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07135MIG. Digoxin generally arises in the molecular formula C41H64O14. The term DIGOXIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, list 3.) DIGOXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule digoxin under HS 29389010 and SITC 54161. As of Q4 2014, DIGOXIN remains US FDA's Preferred Term for this commodity. Digoxin bears US NLM identifiers UMLS ID C0012265 and NCI Concept Code C28990. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(O)C(O)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CC(O)C1(C(CC2)C1=CC(=O)OC1)C.